Paper19852963
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
Lok AS and 11 others. Gastroenterology, 2010. Cited by 475 papers, by iCite.
Cite this record
ConductScience Library. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Papers, record 19852963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19852963
- Disease
- hepatitis C virus infection206 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Biomarkers, Tumor | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Protein Precursors | Major topic |
| alpha-Fetoproteins | Major topic |
| Adult | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Liver | |
| Male | |
| Middle Aged | |
| Prothrombin | |
| Randomized Controlled Trials as Topic | |
| Sensitivity and Specificity | |
| Ultrasonography |
Source PubMed
Grants46
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01-DK-9-2325 | NIDDK NIH HHS | United States | N01DK092325 | PubMed and NIH | NIH RePORTER |
| 1 UL1 RR024986 | NCRR NIH HHS | United States | UL1RR024986 | PubMed and NIH | NIH RePORTER |
| 1 UL1 RR025758-01 | NCRR NIH HHS | United States | UL1RR025758 | PubMed and NIH | NIH RePORTER |
| 1 UL1 RR024982-01 | NCRR NIH HHS | United States | UL1RR024982 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2320 | NIDDK NIH HHS | United States | N01DK092320 | PubMed and NIH | NIH RePORTER |
| M01 RR001066 | NCRR NIH HHS | United States | M01RR001066 | PubMed and NIH | NIH RePORTER |
| M01 RR000065 | NCRR NIH HHS | United States | M01RR000065 | PubMed and NIH | NIH RePORTER |
| UL1 RR024982 | NCRR NIH HHS | United States | UL1RR024982 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2322 | NIDDK NIH HHS | United States | N01DK092322 | PubMed and NIH | NIH RePORTER |
| M01 RR000043 | NCRR NIH HHS | United States | M01RR000043 | PubMed and NIH | NIH RePORTER |
| UL1 RR024986 | NCRR NIH HHS | United States | UL1RR024986 | PubMed and NIH | NIH RePORTER |
| M01RR-00042 | NCRR NIH HHS | United States | M01RR000042 | PubMed and NIH | NIH RePORTER |
| 1 UL1 RR 025780-01 | NCRR NIH HHS | United States | UL1RR025780 | PubMed and NIH | NIH RePORTER |
| N01 DK092324 | NIDDK NIH HHS | United States | N01DK092324 | PubMed and NIH | NIH RePORTER |
| N01 DK092321 | NIDDK NIH HHS | United States | N01DK092321 | PubMed and NIH | NIH RePORTER |
| M01RR-00065 | NCRR NIH HHS | United States | M01RR000065 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2328 | NIDDK NIH HHS | United States | N01DK092328 | PubMed and NIH | NIH RePORTER |
| N01 DK092320 | NIDDK NIH HHS | United States | N01DK092320 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2318 | NIDDK NIH HHS | United States | N01DK092318 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2324 | NIDDK NIH HHS | United States | N01DK092324 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00006164 | Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment | Derived from the trial | Yes |
Source ClinicalTrials.gov
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18848939 | Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. | Gastroenterology | 2009 | https://conductscience.org/library/papers/18848939 | PubMed |
| 2 | 16911460 | Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. | Liver Int | 2006 | https://conductscience.org/library/papers/16911460 | PubMed |
| 3 | 11156649 | Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. | Gut | 2001 | https://conductscience.org/library/papers/11156649 | PubMed |
| 4 | 15465617 | Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. | Control Clin Trials | 2004 | https://conductscience.org/library/papers/15465617 | PubMed |
| 5 | 3036940 | Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study. | J Hepatol | 1987 | https://conductscience.org/library/papers/3036940 | PubMed |
| 6 | 16136646 | Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. | J Hepatol | 2005 | https://conductscience.org/library/papers/16136646 | PubMed |
| 7 | 10520857 | Screening for hepatocellular carcinoma in patients with advanced cirrhosis. | Am J Gastroenterol | 1999 | https://conductscience.org/library/papers/10520857 | PubMed |
| 8 | 11941963 | Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. | Hepatogastroenterology | 2002 | https://conductscience.org/library/papers/11941963 | PubMed |
| 9 | 16848811 | Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. | Am J Gastroenterol | 2006 | https://conductscience.org/library/papers/16848811 | PubMed |
| 10 | 7515408 | Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. | J Hepatol | 1994 | https://conductscience.org/library/papers/7515408 | PubMed |
| 11 | 4528109 | Vitamin K dependent modifications of glutamic acid residues in prothrombin. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4528109 | PubMed |
| 12 | 12834318 | Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. | Ann Intern Med | 2003 | https://conductscience.org/library/papers/12834318 | PubMed |
| 13 | 15042359 | Randomized controlled trial of screening for hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2004 | https://conductscience.org/library/papers/15042359 | PubMed |
| 14 | 19052125 | Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. | N Engl J Med | 2008 | https://conductscience.org/library/papers/19052125 | PubMed |
| 15 | 12717392 | Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. | Hepatology | 2003 | https://conductscience.org/library/papers/12717392 | PubMed |
| 16 | 10763956 | Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. | Am J Gastroenterol | 2000 | https://conductscience.org/library/papers/10763956 | PubMed |
| 17 | 11350553 | Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. | J Gastroenterol Hepatol | 2001 | https://conductscience.org/library/papers/11350553 | PubMed |
| 18 | 6201741 | Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6201741 | PubMed |
| 19 | 10738213 | Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. | Cancer | 2000 | https://conductscience.org/library/papers/10738213 | PubMed |
| 20 | 7506227 | Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. | Hepatology | 1994 | https://conductscience.org/library/papers/7506227 | PubMed |
Cited by285
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 475 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42976211 | PIVKA-II and hematological parameters in hepatocellular carcinoma and non-malignant chronic liver disease: A case-control biomarker comparison in a hepatitis-endemic population. | PLoS One | 2026 | https://conductscience.org/library/papers/42976211 | PubMed |
| 42936682 | Isolated Metachronous Splenic Metastasis Following Discontinuation of PD-1 Inhibitor Therapy in Hepatocellular Carcinoma: A Rare Pattern of Late Recurrence - A Case Report. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42936682 | PubMed |
| 42543507 | Lock-Open: An AND Logic-Gated, Entropy-Driven DNA Nanowalker for Highly Sensitive Detection of UDG and APE1 Activities in Hepatocellular Carcinoma. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42543507 | PubMed |
| 42403532 | The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42403532 | PubMed |
| 41981115 | The versatile interplay between steatotic liver disease and liver cancer. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41981115 | PubMed |
| 41976309 | Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976309 | PubMed |
| 41907234 | Case Report: Serum AKR1B10 as a complementary marker for the detection of AFP-negative hepatocellular carcinoma - a report of two cases. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41907234 | PubMed |
| 41815132 | Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41815132 | PubMed |
| 41770443 | Diagnostic utility of postmortem serum tumor markers for identifying primary malignancies: A forensic evaluation of six markers. | Forensic Sci Med Pathol | 2026 | https://conductscience.org/library/papers/41770443 | PubMed |
| 41659855 | Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41659855 | PubMed |
| 41647967 | Novel blood signature for hepatocellular carcinoma screening. | ESMO Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/41647967 | PubMed |
| 41294084 | Fontan-Associated Liver Disease: Trends Over Time and Relationship With Outcomes. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/41294084 | PubMed |
| 40689369 | Comparison of the GALAD, GAAP, and ASAP Scores for Hepatocellular Carcinoma Detection in Patients With Chronic Liver Diseases. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40689369 | PubMed |
| 40566050 | Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation. | J Clin Med | 2025 | https://conductscience.org/library/papers/40566050 | PubMed |
| 40504251 | Cancer surveillance in biliary atresia patients with native liver survival: Standardizing monitoring and follow-up. | Pediatr Surg Int | 2025 | https://conductscience.org/library/papers/40504251 | PubMed |
| 40074769 | Integrated analysis and experimental validation reveal the prognostic and immunological features associated with coagulation in hepatocellular carcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40074769 | PubMed |
| 39807403 | Correlation Between Dynamic Contrast-Enhanced CT Imaging Signs and Differentiation Grade and Microvascular Invasion of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2025 | https://conductscience.org/library/papers/39807403 | PubMed |
| 39685591 | Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy-A Narrative Review. | J Clin Med | 2024 | https://conductscience.org/library/papers/39685591 | PubMed |
| 39682122 | Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682122 | PubMed |
| 39649218 | Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma. | World J Gastrointest Surg | 2024 | https://conductscience.org/library/papers/39649218 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| PEGINTERFERON ALFA-2A | CHEMBL1201560 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201560 | ChEMBL |
| RIBAVIRIN | CHEMBL1643 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1643 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19852963
GET https://conductscience.org/api/papers/v1/19852963/grants?page=2